4 Podcast Episodes
Myeloma Crowd Radio: Ravi Vij, MD, Washington University
Myeloma Crowd Radio: Ravi Vij, MD, Washington University
A new monoclonal antibody called Isatuximab is advancing through clinical trials and is getting closer to FDA approval. ... Read more
6 Feb 2019
•
1hr 1min
Myeloma Crowd Radio: Dr. Ravi Vij, MD, Washington University
Myeloma Crowd Radio: Dr. Ravi Vij, MD, Washington University
Are there new treatment options for the relapsed/refractory myeloma patient? Dr. Ravi Vij, MD of Washington University S... Read more
29 Jan 2015
•
1hr 5mins
RWIMM1 2012 | Roundtable Discussion with Rafael Fonseca, MD and Ravi Vij, MD
RWIMM1 2012 | Roundtable Discussion with Rafael Fonseca, MD and Ravi Vij, MD
Rounds with the Investigators: National Research Leaders Provide Their Perspectives on the Management of Actual Patients... Read more
24 Jul 2012
•
1hr 3mins
CACU2 2010 | Interview with Ravi Vij, MD
CACU2 2010 | Interview with Ravi Vij, MD
ResearchToPractice.com/CACU210 – Interview with Ravi Vij, MD conducted by Neil Love, MD. Produced by Research To Practic... Read more
16 Sep 2010
•
32mins